Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1987 1
1992 1
1994 6
1995 7
1996 10
1997 11
1998 4
1999 7
2000 7
2001 5
2002 2
2003 2
2004 1
2005 3
2006 3
2007 1
2008 1
2009 3
2010 4
2011 5
2012 5
2013 4
2014 4
2015 2
2016 1
2017 2
2018 2
2019 2
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Results by year
Filters applied: . Clear all
Page 1
Anti-bacterial Monoclonal Antibodies.
Nagy E, Nagy G, Power CA, Badarau A, Szijártó V. Nagy E, et al. Among authors: power ca. Adv Exp Med Biol. 2017;1053:119-153. doi: 10.1007/978-3-319-72077-7_7. Adv Exp Med Biol. 2017. PMID: 29549638 Review.
Evasins: Tick Salivary Proteins that Inhibit Mammalian Chemokines.
Bhusal RP, Eaton JRO, Chowdhury ST, Power CA, Proudfoot AEI, Stone MJ, Bhattacharya S. Bhusal RP, et al. Among authors: power ca. Trends Biochem Sci. 2020 Feb;45(2):108-122. doi: 10.1016/j.tibs.2019.10.003. Epub 2019 Nov 1. Trends Biochem Sci. 2020. PMID: 31679840 Free PMC article. Review.
Targeting chemokines: Pathogens can, why can't we?
Proudfoot AE, Bonvin P, Power CA. Proudfoot AE, et al. Among authors: power ca. Cytokine. 2015 Aug;74(2):259-67. doi: 10.1016/j.cyto.2015.02.011. Epub 2015 Mar 6. Cytokine. 2015. PMID: 25753743 Review.
Chemokine blockers--therapeutics in the making?
Wells TN, Power CA, Shaw JP, Proudfoot AE. Wells TN, et al. Among authors: power ca. Trends Pharmacol Sci. 2006 Jan;27(1):41-7. doi: 10.1016/j.tips.2005.11.001. Epub 2005 Nov 28. Trends Pharmacol Sci. 2006. PMID: 16310864 Review.
From bench to bedside: immunotherapy for prostate cancer.
Tse BW, Jovanovic L, Nelson CC, de Souza P, Power CA, Russell PJ. Tse BW, et al. Among authors: power ca. Biomed Res Int. 2014;2014:981434. doi: 10.1155/2014/981434. Epub 2014 Sep 4. Biomed Res Int. 2014. PMID: 25276838 Free PMC article. Review.
Strategies for chemokine antagonists as therapeutics.
Proudfoot AE, Power CA, Rommel C, Wells TN. Proudfoot AE, et al. Among authors: power ca. Semin Immunol. 2003 Feb;15(1):57-65. doi: 10.1016/s1044-5323(02)00128-8. Semin Immunol. 2003. PMID: 12495641 Review.
Anti-chemokine small molecule drugs: a promising future?
Proudfoot AE, Power CA, Schwarz MK. Proudfoot AE, et al. Among authors: power ca. Expert Opin Investig Drugs. 2010 Mar;19(3):345-55. doi: 10.1517/13543780903535867. Expert Opin Investig Drugs. 2010. PMID: 20113217 Review.
Protein therapeutics--lessons learned and a view of the future.
Johnson-Léger C, Power CA, Shomade G, Shaw JP, Proudfoot AE. Johnson-Léger C, et al. Among authors: power ca. Expert Opin Biol Ther. 2006 Jan;6(1):1-7. doi: 10.1517/14712598.6.1.1. Expert Opin Biol Ther. 2006. PMID: 16370909 Review.
Selectivity and antagonism of chemokine receptors.
Wells TN, Power CA, Lusti-Narasimhan M, Hoogewerf AJ, Cooke RM, Chung CW, Peitsch MC, Proudfoot AE. Wells TN, et al. Among authors: power ca. J Leukoc Biol. 1996 Jan;59(1):53-60. doi: 10.1002/jlb.59.1.53. J Leukoc Biol. 1996. PMID: 8558067 Review.
103 results